We are live on ! Find out more
PNT

POINT Biopharma Global Inc. Common Stock
PNT

Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of PNT yet.

PNT Hedge Fund Activity: Q1 2024 in Review

0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in POINT Biopharma Global Inc. Common Stock (PNT) for Q1 2024, worth a combined $0 — down 100% from $1K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PNT and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Blue Trust Inc, exiting entirely with an estimated $1K sold.

  • 0 institutional investors held POINT Biopharma Global Inc. Common Stock (PNT) as of Q1 2024, down from 1 in Q4 2023.
  • Funds reported $0 of POINT Biopharma Global Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new POINT Biopharma Global Inc. Common Stock positions in Q1 2024 and 1 closed out, a net change of -1 holder.
  • The largest POINT Biopharma Global Inc. Common Stock seller in Q1 2024 was Blue Trust Inc, an estimated $1K sold.

Based on aggregated 13F filings for Q1 2024.